Impact of SARS-CoV-2 vaccination in patients with vascular liver diseases: Observations from a VALDIG multicenter study

Patients with vascular liver disease (VLD) are at increased risk of both SARS-CoV-2 infection and severe COVID-19 disease. The potential risks associated with vaccination against this infection need thorough investigation. Our research enhances the understanding of the effects of COVID-19 vaccination in patients with VLD, highlighting its good tolerability. Moreover, patients with VLD appear to have a preserved immune response to SARS-CoV-2 vaccination, providing protection against severe COVID-19 infection. Our study cannot definitively establish a direct link between vaccination and thrombotic events, and no cases of vaccine-induced thrombocytopenia were reported.

Authors

Institutions

Publication Details

Journal
JHEP Reports
Published
2024-08-23
DOI
https://doi.org/10.1016/j.jhepr.2024.101191
Citations
1
Primary Topic
Liver Disease and Transplantation
Type
article
Field-Weighted Citation Impact
0.37
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impact of SARS-CoV-2 vaccination in patients with vascular liver diseases: Observations from a VALDIG multicenter study

Juan Carlos García‐Pagán, Aurélie Plessier, Maria Cristina Morelli, Xavier Verhelst et al.
1 citations
JHEP Reports
Liver Disease and Transplantation
0.37
article

Impact of SARS-CoV-2 vaccination in patients with vascular liver diseases: Observations from a VALDIG multicenter study

Juan Carlos García‐Pagán, Aurélie Plessier, Maria Cristina Morelli, Xavier Verhelst, Lara Orts, Luis Ibáñez, Ángela Puente, Julian Schulze zur Wiesch, Jonel Trebicka, Eleanor Barnes, Anna Baiges, Edilmar Alvarado‐Tápias, Thomas Marjot, Carlos González‐Alayón, Valeria Pérez‐Campuzano, Pierre‐Emmanuel Rautou, Elba Llop, Macarena Simón‐Talero, Michael Praktiknjo, Georgina Meacham, Laura Turco, Luís Téllez, Càndid Villanueva, Virginia Hernández–Gea, Thomas Reiberger, G Grassi, Payance Audrey, Johanna Birte Bergmann, Sam Murray, Carmen Álvarez‐Navascués, Marc Luetgehetmann
article en
1 citations

Abstract

Patients with vascular liver disease (VLD) are at increased risk of both SARS-CoV-2 infection and severe COVID-19 disease. The potential risks associated with vaccination against this infection need thorough investigation. Our research enhances the understanding of the effects of COVID-19 vaccination in patients with VLD, highlighting its good tolerability. Moreover, patients with VLD appear to have a preserved immune response to SARS-CoV-2 vaccination, providing protection against severe COVID-19 infection. Our study cannot definitively establish a direct link between vaccination and thrombotic events, and no cases of vaccine-induced thrombocytopenia were reported.

JHEP ReportsVol. 6(12)
Inserm (FR), Universität Hamburg (DE), Université Paris Cité (FR), University of Münster (DE), University Hospital Bonn (DE), Hôpital Beaujon (FR), Hospital Universitario de Canarias (ES), Ghent University Hospital (BE), Hospital de Sant Pau (ES), Hospital General Universitario Gregorio Marañón (ES), University of Oxford (GB), Assistance Publique – Hôpitaux de Paris (FR), Marqués de Valdecilla University Hospital (ES), Hospital Universitario Puerta de Hierro Majadahonda (ES), University Medical Center Hamburg-Eppendorf (DE), German Center for Infection Research (DE), Azienda USL di Bologna (IT), Vall d'Hebron Hospital Universitari (ES), Centre de Recherche sur l'Inflammation (FR), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (ES), Hospital Universitario Central de Asturias (ES), Hospital Universitario Ramón y Cajal (ES), Medical University of Vienna (AT)
Good health and well-being
Openalex Percentile: Top 38%
Liver Disease and Transplantation
0.37
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.